跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 64,165 条关于
“bispecific T-cell engager”
全部
64,165
临床试验
44,518
药物
6,347
机构
223
资讯
13,077
去年
Cullinan Therapeutics Licenses BCMA-Targeted Bispecific T Cell Engager for Autoimmune Disease Development
去年
Otsuka Pharmaceutical Secures Global Rights to HBM7020 BCMAxCD3 Bispecific T-Cell Engager for Autoimmune Diseases
3个月前
Author Correction Issued for MAGE-A4/MAGE-A8-Targeted TCR-Based Bispecific T Cell Engager Study
7个月前
Florida Cancer Specialists Launches Phase 3 Trial of Pasritamig Bispecific T-Cell Engager for Castration-Resistant Prostate Cancer
去年
Merck & Co. Acquires Curon Bio's Bispecific T-Cell Engager for $1.3 Billion
25天前
Astellas Doses First Patient in Phase 3 Study of ASP2138, a Subcutaneous Bispecific T-Cell Engager for CLDN18.2-Positive Gastric Cancer
2个月前
92Bio Doses First Patient in Phase 1 Trial of NTB-928, a Next-Generation Bispecific T-Cell Engager for Platinum-Resistant Ovarian Cancer
2年前
FDA Approves First Bispecific T-Cell Engager for Solid Tumors and Expands Indications for Immunotherapies
去年
Expert Highlights Optimal Positioning of Bispecific T-Cell Engagers in Multiple Myeloma Treatment
3年前
FDA Approves Two Bispecific T-Cell Engagers for Relapsed/Refractory B-Cell Lymphomas
第 1 页,共 1308 页
上一页
下一页